MEDICENNA THERAPEUTICS CORP.

Analyst Reco. Medicenna Therapeutics Corp.

Equities

MDNA

CA58490H1073

Market Closed - Toronto S.E. Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
2.47 ^CAD	-10.83%		+3.35%	+488.10%

04-30	Medicenna Therapeutics Corp. announced that it has received CAD 20 million in funding from RA Capital Management, L.P.	CI
04-26	Medicenna Therapeutics Corp. announced that it expects to receive CAD 20 million in funding	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Medicenna Therapeutics Price Target to $3 From $8, Maintains Outperform Rating	14/08/23	MT
HC Wainwright Reiterates Medicenna Therapeutics at Buy With $2.50 Price Target	08/02/23	MT
HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $2.50 From $4, Maintains Buy Rating	08/11/22	MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $4 From $5, Keeps Buy Rating	16/08/22	MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $8 From $10, Maintains Outperform Rating	10/08/22	MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $5 from $7, Keeps Buy Rating	23/06/22	MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $10 From $12, Maintains Outperform Rating	23/06/22	MT
MEDICENNA THERAPEUTICS : HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $7 From $8, Maintains Buy Rating	01/06/21	MT
MEDICENNA THERAPEUTICS : Oppenheimer Starts Medicenna Therapeutics at Outperform With $12 Price Target	18/12/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer